Obstructive Sleep Apnea and Type 2 Diabetes
Canadian Diabetes & Endocrinology Today · 2024
DOI: 10.58931/cdet.2024.2227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Diabetes & Endocrinology Today, 2024. Verfasst von Aaron LeBlanc. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) and type 2 diabetes (T2D) are commonly encountered diseases in clinical practice, and there appears to be a bidirectional relationship between these 2 diseases. The presence of OSA can increase the risk of developing T2D, increase the risk of micro- and macro-vascular complications, and increase the risk of mortality. Several management strategies are available that can positively impact the outcomes of patients living with co-existing T2D and OSA. Given this bidirectional relationship, the negative consequences of untreated OSA on outcomes in T2D, along with the currently available management strategies, screening for OSA in patients with T2D should be considered.
Zitieren
APA
LeBlanc, A. (2024). Obstructive Sleep Apnea and Type 2 Diabetes. Canadian Diabetes & Endocrinology Today. https://doi.org/10.58931/cdet.2024.2227
Vancouver
LeBlanc A. Obstructive Sleep Apnea and Type 2 Diabetes. Canadian Diabetes & Endocrinology Today. 2024. doi:10.58931/cdet.2024.2227
BibTeX
@article{LeBlanc2024,
author = {LeBlanc, Aaron},
title = {Obstructive Sleep Apnea and Type 2 Diabetes},
journal = {Canadian Diabetes & Endocrinology Today},
year = {2024},
doi = {10.58931/cdet.2024.2227}
}
EUVIMED